{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:33:55Z","timestamp":1790926435200,"version":"4.1.0"},"reference-count":56,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"26","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Transl. Med."],"published-print":{"date-parts":[[2010,4,7]]},"abstract":"<jats:p>A cancer-associated signaling pathway is reversibly activated in the normal airways of smokers before they develop lung cancer, presenting an opportunity for preventive therapy.<\/jats:p>","DOI":"10.1126\/scitranslmed.3000251","type":"journal-article","created":{"date-parts":[[2010,4,7]],"date-time":"2010-04-07T21:38:01Z","timestamp":1270676281000},"source":"Crossref","is-referenced-by-count":224,"title":["Airway PI3K Pathway Activation Is an Early and Reversible Event in Lung Cancer Development"],"prefix":"10.1126","volume":"2","author":[{"given":"Adam M.","family":"Gustafson","sequence":"first","affiliation":[{"name":"Section of Computational Biomedicine, Department of Medicine and Pulmonary Center, Boston University Medical Center, Boston, MA 02118, USA."},{"name":"Bioinformatics Program, Boston University, Boston, MA 02118, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Soldi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84112, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Anderlind","sequence":"additional","affiliation":[{"name":"Section of Computational Biomedicine, Department of Medicine and Pulmonary Center, Boston University Medical Center, Boston, MA 02118, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Beth","family":"Scholand","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Utah, Salt Lake City, UT 84112, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Qian","sequence":"additional","affiliation":[{"name":"Division of Allergy Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt-Ingram Comprehensive Cancer Center and Nashville Veterans Affairs Medical Center, Nashville, TN 37232, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Section of Computational Biomedicine, Department of Medicine and Pulmonary Center, Boston University Medical Center, Boston, MA 02118, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendal","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84112, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Walker","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84112, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"McWilliams","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, British Columbia Cancer Agency, Vancouver, British Columbia, Canada V5Z 4E6."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Liu","sequence":"additional","affiliation":[{"name":"Section of Computational Biomedicine, Department of Medicine and Pulmonary Center, Boston University Medical Center, Boston, MA 02118, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Szabo","sequence":"additional","affiliation":[{"name":"Lung and Upper Aerodigestive Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Brody","sequence":"additional","affiliation":[{"name":"Section of Computational Biomedicine, Department of Medicine and Pulmonary Center, Boston University Medical Center, Boston, MA 02118, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre P.","family":"Massion","sequence":"additional","affiliation":[{"name":"Division of Allergy Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt-Ingram Comprehensive Cancer Center and Nashville Veterans Affairs Medical Center, Nashville, TN 37232, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc E.","family":"Lenburg","sequence":"additional","affiliation":[{"name":"Section of Computational Biomedicine, Department of Medicine and Pulmonary Center, Boston University Medical Center, Boston, MA 02118, USA."},{"name":"Bioinformatics Program, Boston University, Boston, MA 02118, USA."},{"name":"Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA 02118, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Lam","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, British Columbia Cancer Agency, Vancouver, British Columbia, Canada V5Z 4E6."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea H.","family":"Bild","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84112, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avrum","family":"Spira","sequence":"additional","affiliation":[{"name":"Section of Computational Biomedicine, Department of Medicine and Pulmonary Center, Boston University Medical Center, Boston, MA 02118, USA."},{"name":"Bioinformatics Program, Boston University, Boston, MA 02118, USA."},{"name":"Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA 02118, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_2_2_2","unstructured":"U.S. Department of Health and Human Services The health consequences of smoking: A report of the Surgeon General\u2014Executive summary (U.S. Department of Health and Human Services Centers for Disease Control and Prevention National Center for Chronic Disease Prevention and Health Promotion Office on Smoking and Health Rockville 2004). http:\/\/www.surgeongeneral.gov\/library\/smokingconsequences"},{"key":"e_1_3_2_3_2","first-page":"2025","article-title":"Loss of heterozygosity in epithelial cells obtained by bronchial brushing: Clinical utility in lung cancer.","volume":"5","author":"Powell C. A.","year":"1999","unstructured":"Powell C. A., Klares S., O\u2019Connor G., Brody J. S., Loss of heterozygosity in epithelial cells obtained by bronchial brushing: Clinical utility in lung cancer. Clin. Cancer Res. 5, 2025\u20132034 (1999).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/jnci\/89.18.1366","article-title":"Molecular damage in the bronchial epithelium of current and former smokers.","volume":"89","author":"Wistuba I. I.","year":"1997","unstructured":"Wistuba I. I., Lam S., Behrens C., Virmani A. K., Fong K. M., LeRiche J., Samet J. M., Srivastava S., Minna J. D., Gazdar A. F., Molecular damage in the bronchial epithelium of current and former smokers. J. Natl. Cancer Inst. 89, 1366\u20131373 (1997).","journal-title":"J. Natl. Cancer Inst."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1158\/1078-0432.CCR-03-0763","article-title":"Promoter hypermethylation of resected bronchial margins: A field defect of changes?","volume":"10","author":"Guo M.","year":"2004","unstructured":"Guo M., House M. G., Hooker C., Han Y., Heath E., Gabrielson E., Yang S. C., Baylin S. B., Herman J. G., Brock M. V., Promoter hypermethylation of resected bronchial margins: A field defect of changes? Clin. Cancer Res. 10, 5131\u20135136 (2004).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1172\/JCI119748","article-title":"Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis.","volume":"100","author":"Franklin W. A.","year":"1997","unstructured":"Franklin W. A., Gazdar A. F., Haney J., Wistuba I. I., La Rosa F. G., Kennedy T., Ritchey D. M., Miller Y. E., Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis. J. Clin. Invest. 100, 2133\u20132137 (1997).","journal-title":"J. Clin. Invest."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"9623","DOI":"10.1158\/0008-5472.CAN-05-0976","article-title":"Telomerase expression in noncancerous bronchial epithelia is a possible marker of early development of lung cancer.","volume":"65","author":"Miyazu Y. M.","year":"2005","unstructured":"Miyazu Y. M., Miyazawa T., Hiyama K., Kurimoto N., Iwamoto Y., Matsuura H., Kanoh K., Kohno N., Nishiyama M., Hiyama E., Telomerase expression in noncancerous bronchial epithelia is a possible marker of early development of lung cancer. Cancer Res. 65, 9623\u20139627 (2005).","journal-title":"Cancer Res."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/1097-0142(197001)25:1<92::AID-CNCR2820250114>3.0.CO;2-E","article-title":"Histologic changes in the larynx in relation to smoking habits.","volume":"25","author":"Auerbach O.","year":"1970","unstructured":"Auerbach O., Hammond E. C., Garfinkel L., Histologic changes in the larynx in relation to smoking habits. Cancer 25, 92\u2013104 (1970). Medline","journal-title":"Cancer"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"10143","DOI":"10.1073\/pnas.0401422101","article-title":"Effects of cigarette smoke on the human airway epithelial cell transcriptome.","volume":"101","author":"Spira A.","year":"2004","unstructured":"Spira A., Beane J., Shah V., Liu G., Schembri F., Yang X., Palma J., Brody J. S., Effects of cigarette smoke on the human airway epithelial cell transcriptome. Proc. Natl. Acad. Sci. U.S.A. 101, 10143\u201310148 (2004).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nm1556","article-title":"Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer.","volume":"13","author":"Spira A.","year":"2007","unstructured":"Spira A., Beane J. E., Shah V., Steiling K., Liu G., Schembri F., Gilman S., Dumas Y. M., Calner P., Sebastiani P., Sridhar S., Beamis J., Lamb C., Anderson T., Gerry N., Keane J., Lenburg M. E., Brody J. S., Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat. Med. 13, 361\u2013366 (2007).","journal-title":"Nat. Med."},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1158\/1940-6207.CAPR-08-0011","article-title":"A prediction model for lung cancer diagnosis that integrates genomic and clinical features.","volume":"1","author":"Beane J.","year":"2008","unstructured":"Beane J., Sebastiani P., Whitfield T. H., Steiling K., Dumas Y. M., Lenburg M. E., Spira A., A prediction model for lung cancer diagnosis that integrates genomic and clinical features. Cancer Prev. Res. 1, 56\u201364 (2008).","journal-title":"Cancer Prev. Res."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature04296","article-title":"Oncogenic pathway signatures in human cancers as a guide to targeted therapies.","volume":"439","author":"Bild A. H.","year":"2006","unstructured":"Bild A. H., Yao G., Chang J. T., Wang Q., Potti A., Chasse D., Joshi M. B., Harpole D., Lancaster J. M., Berchuck A., Olson J. A., Marks J. R., Dressman H. K., West M., Nevins J. R., Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439, 353\u2013357 (2006).","journal-title":"Nature"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1056\/NEJMe068292","article-title":"Sorting out breast-cancer gene signatures.","volume":"356","author":"Massagu\u00e9 J.","year":"2007","unstructured":"Massagu\u00e9 J., Sorting out breast-cancer gene signatures. N. Engl. J. Med. 356, 294\u2013297 (2007).","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1158\/0008-5472.CAN-06-3633","article-title":"Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: Rationale for patient selection.","volume":"67","author":"Huang F.","year":"2007","unstructured":"Huang F., Reeves K., Han X., Fairchild C., Platero S., Wong T. W., Lee F., Shaw P., Clark E., Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: Rationale for patient selection. Cancer Res. 67, 2226\u20132238 (2007).","journal-title":"Cancer Res."},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/01.JTO.0000263718.69320.4c","article-title":"A translational view of the molecular pathogenesis of lung cancer.","volume":"2","author":"Sato M.","year":"2007","unstructured":"Sato M., Shames D. S., Gazdar A. F., Minna J. D., A translational view of the molecular pathogenesis of lung cancer. J. Thorac. Oncol. 2, 327\u2013343 (2007).","journal-title":"J. Thorac. Oncol."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1593\/neo.07292"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10549-006-9463-x","article-title":"Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type\/\u201ctriple-negative\u201d breast cancer cell lines growing in vitro.","volume":"105","author":"Finn R. S.","year":"2007","unstructured":"Finn R. S., Dering J., Ginther C., Wilson C. A., Glaspy P., Tchekmedyian N., Slamon D. J., Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type\/\u201ctriple-negative\u201d breast cancer cell lines growing in vitro. Breast Cancer Res. Treat. 105, 319\u2013326 (2007).","journal-title":"Breast Cancer Res. Treat."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0608396103"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature03664"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1125951"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1099314"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature06915","article-title":"Enabling personalized cancer medicine through analysis of gene-expression patterns.","volume":"452","author":"van\u2019t Veer L. J.","year":"2008","unstructured":"van\u2019t Veer L. J., Bernards R., Enabling personalized cancer medicine through analysis of gene-expression patterns. Nature 452, 564\u2013570 (2008).","journal-title":"Nature"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1902"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.critrevonc.2007.04.002","article-title":"Targeting mTOR signaling in lung cancer.","volume":"63","author":"Marinov M.","year":"2007","unstructured":"Marinov M., Fischer B., Arcaro A., Targeting mTOR signaling in lung cancer. Crit. Rev. Oncol. Hematol. 63, 172\u2013182 (2007).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2554494"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc969"},{"key":"e_1_3_2_27_2","first-page":"481","article-title":"Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers.","volume":"27","author":"Grepmeier U.","year":"2005","unstructured":"Grepmeier U., Dietmaier W., Merk J., Wild P. J., Obermann E. C., Pfeifer M., Hofstaedter F., Hartmann A., Woenckhaus M., Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers. Int. J. Oncol. 27, 481\u2013488 (2005).","journal-title":"Int. J. Oncol."},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"15948","DOI":"10.1073\/pnas.0504300102","article-title":"Distinctions in the specificity of E2F function revealed by gene expression signatures.","volume":"102","author":"Black E. P.","year":"2005","unstructured":"Black E. P., Hallstrom T., Dressman H. K., West M., Nevins J. R., Distinctions in the specificity of E2F function revealed by gene expression signatures. Proc. Natl. Acad. Sci. U.S.A. 102, 15948\u201315953 (2005).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"e_1_3_2_29_2","first-page":"3716","article-title":"Distinct gene expression phenotypes of cells lacking Rb and Rb family members.","volume":"63","author":"Black E. P.","year":"2003","unstructured":"Black E. P., Huang E., Dressman H., Rempel R., Laakso N., Asa S. L., Ishida S., West M., Nevins J. R., Distinct gene expression phenotypes of cells lacking Rb and Rb family members. Cancer Res. 63, 3716\u20133723 (2003).","journal-title":"Cancer Res."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1167"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkm882"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2204"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1055\/s-2005-858638","article-title":"Mechanisms of disease: PI3K\/AKT signaling in gastrointestinal cancers.","volume":"43","author":"Michl P.","year":"2005","unstructured":"Michl P., Downward J., Mechanisms of disease: PI3K\/AKT signaling in gastrointestinal cancers. Z. Gastroenterol. 43, 1133\u20131139 (2005).","journal-title":"Z. Gastroenterol."},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.022459"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"R201","DOI":"10.1186\/gb-2007-8-9-r201","article-title":"Reversible and permanent effects of tobacco smoke exposure on airway epithelial gene expression.","volume":"8","author":"Beane J.","year":"2007","unstructured":"Beane J., Sebastiani P., Liu G., Brody J. S., Lenburg M. E., Spira A., Reversible and permanent effects of tobacco smoke exposure on airway epithelial gene expression. Genome Biol. 8, R201 (2007).","journal-title":"Genome Biol."},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001651"},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.1158\/0008-5472.CAN-09-2066","article-title":"Atypical protein kinase C\u03b9 is required for bronchioalveolar stem cell expansion and lung tumorigenesis.","volume":"69","author":"Regala R. P.","year":"2009","unstructured":"Regala R. P., Davis R. K., Kunz A., Khoor A., Leitges M., Fields A. P., Atypical protein kinase C\u03b9 is required for bronchioalveolar stem cell expansion and lung tumorigenesis. Cancer Res. 69, 7603\u20137611 (2009).","journal-title":"Cancer Res."},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1476-4598-8-9","article-title":"Protein kinase C\u03b5: An oncogene and emerging tumor biomarker.","volume":"8","author":"Gorin M. A.","year":"2009","unstructured":"Gorin M. A., Pan Q., Protein kinase C\u03b5: An oncogene and emerging tumor biomarker. Mol. Cancer 8, 9 (2009).","journal-title":"Mol. Cancer"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2008.244"},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1042\/BST0330350","article-title":"Atypical protein kinase C in insulin action and insulin resistance.","volume":"33","author":"Farese R. V.","year":"2005","unstructured":"Farese R. V., Sajan M. P., Standaert M. L., Atypical protein kinase C in insulin action and insulin resistance. Biochem. Soc. Trans. 33, 350\u2013353 (2005).","journal-title":"Biochem. Soc. Trans."},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2000014"},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/sj.onc.1201949","article-title":"Distinct regions of allelic imbalance on chromosome 10q22-q26 in squamous cell carcinomas of the lung.","volume":"17","author":"Petersen S.","year":"1998","unstructured":"Petersen S., Rudolf J., Bockm\u00fchl U., Gellert K., Wolf G., Dietel M., Petersen I., Distinct regions of allelic imbalance on chromosome 10q22-q26 in squamous cell carcinomas of the lung. Oncogene 17, 449\u2013454 (1998).","journal-title":"Oncogene"},{"key":"e_1_3_2_44_2","first-page":"5221","article-title":"MMAC1\/PTEN mutations in primary tumor specimens and tumor cell lines.","volume":"57","author":"Teng D. H.","year":"1997","unstructured":"Teng D. H., Hu R., Lin H., Davis T., Iliev D., Frye C., Swedlund B., Hansen K. L., Vinson V. L., Gumpper K. L., Ellis L., El-Naggar A., Frazier M., Jasser S., Langford L. A., Lee J., Mills G. B., Pershouse M. A., Pollack R. E., Tornos C., Troncoso P., Yung W. K., Fujii G., Berson A., Bookstein R., Bolen J. B., Tavtigian S. V., Steck P. A., MMAC1\/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res. 57, 5221\u20135225 (1997).","journal-title":"Cancer Res."},{"key":"e_1_3_2_45_2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3748\/wjg.v11.i2.285","article-title":"Loss of heterozygosity on 10q23.3 and mutation of tumor suppressor gene PTEN in gastric cancer and precancerous lesions.","volume":"11","author":"Li Y. L.","year":"2005","unstructured":"Li Y. L., Tian Z., Wu D. Y., Fu B. Y., Xin Y., Loss of heterozygosity on 10q23.3 and mutation of tumor suppressor gene PTEN in gastric cancer and precancerous lesions. World J. Gastroenterol. 11, 285\u2013288 (2005).","journal-title":"World J. Gastroenterol."},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.202610899"},{"key":"e_1_3_2_47_2","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1158\/1055-9965.EPI-06-0128","article-title":"A phase I study of myo-inositol for lung cancer chemoprevention.","volume":"15","author":"Lam S.","year":"2006","unstructured":"Lam S., McWilliams A., LeRiche J., MacAulay C., Wattenberg L., Szabo E., A phase I study of myo-inositol for lung cancer chemoprevention. Cancer Epidemiol. Biomarkers Prev. 15, 1526\u20131531 (2006).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"e_1_3_2_48_2","first-page":"2873","article-title":"Inositol hexaphosphate inhibits cell transformation and activator protein 1 activation by targeting phosphatidylinositol-3\u2032 kinase.","volume":"57","author":"Huang C.","year":"1997","unstructured":"Huang C., Ma W. Y., Hecht S. S., Dong Z., Inositol hexaphosphate inhibits cell transformation and activator protein 1 activation by targeting phosphatidylinositol-3\u2032 kinase. Cancer Res. 57, 2873\u20132878 (1997).","journal-title":"Cancer Res."},{"key":"e_1_3_2_49_2","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1038\/sj.onc.1207296","article-title":"Inositol pentakisphosphate promotes apoptosis through the PI 3-K\/Akt pathway.","volume":"23","author":"Piccolo E.","year":"2004","unstructured":"Piccolo E., Vignati S., Maffucci T., Innominato P. F., Riley A. M., Potter B. V., Pandolfi P. P., Broggini M., Iacobelli S., Innocenti P., Falasca M., Inositol pentakisphosphate promotes apoptosis through the PI 3-K\/Akt pathway. Oncogene 23, 1754\u20131765 (2004).","journal-title":"Oncogene"},{"key":"e_1_3_2_50_2","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1038\/sj.onc.1203931","article-title":"Expression of the BRK tyrosine kinase in mammary epithelial cells enhances the coupling of EGF signalling to PI 3-kinase and Akt, via erbB3 phosphorylation.","volume":"19","author":"Kamalati T.","year":"2000","unstructured":"Kamalati T., Jolin H. E., Fry M. J., Crompton M. R., Expression of the BRK tyrosine kinase in mammary epithelial cells enhances the coupling of EGF signalling to PI 3-kinase and Akt, via erbB3 phosphorylation. Oncogene 19, 5471\u20135476 (2000).","journal-title":"Oncogene"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409773102"},{"key":"e_1_3_2_52_2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1158\/1940-6207.CAPR-08-0209","article-title":"The chemopreventive agent myoinositol inhibits Akt and extracellular signal-regulated kinase in bronchial lesions from heavy smokers.","volume":"2","author":"Han W.","year":"2009","unstructured":"Han W., Gills J. J., Memmott R. M., Lam S., Dennis P. A., The chemopreventive agent myoinositol inhibits Akt and extracellular signal-regulated kinase in bronchial lesions from heavy smokers. Cancer Prev. Res. 2, 370\u2013376 (2009).","journal-title":"Cancer Prev. Res."},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1753"},{"key":"e_1_3_2_54_2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/138920207782446160","article-title":"The phosphoinositide 3-kinase pathway in human cancer: Genetic alterations and therapeutic implications.","volume":"8","author":"Arcaro A.","year":"2007","unstructured":"Arcaro A., Guerreiro A. S., The phosphoinositide 3-kinase pathway in human cancer: Genetic alterations and therapeutic implications. Curr. Genomics 8, 271\u2013306 (2007).","journal-title":"Curr. Genomics"},{"key":"e_1_3_2_55_2","doi-asserted-by":"crossref","first-page":"6913","DOI":"10.1158\/0008-5472.CAN-07-5084","article-title":"PIK3CA mutations and copy number gains in human lung cancers.","volume":"68","author":"Yamamoto H.","year":"2008","unstructured":"Yamamoto H., Shigematsu H., Nomura M., Lockwood W. W., Sato M., Okumura N., Soh J., Suzuki M., Wistuba I. I., Fong K. M., Lee H., Toyooka S., Date H., Lam W. L., Minna J. D., Gazdar A. F., PIK3CA mutations and copy number gains in human lung cancers. Cancer Res. 68, 6913\u20136921 (2008).","journal-title":"Cancer Res."},{"key":"e_1_3_2_56_2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/bioinformatics\/btg385","article-title":"Adjustment of systematic microarray data biases.","volume":"20","author":"Benito M.","year":"2004","unstructured":"Benito M., Parker J., Du Q., Wu J., Xiang D., Perou C. M., Marron J. S., Adjustment of systematic microarray data biases. Bioinformatics 20, 105\u2013114 (2004).","journal-title":"Bioinformatics"},{"key":"e_1_3_2_57_2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/315239a0","article-title":"Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation.","volume":"315","author":"Whitman M.","year":"1985","unstructured":"Whitman M., Kaplan D. R., Schaffhausen B., Cantley L., Roberts T. M., Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation. Nature 315, 239\u2013242 (1985).","journal-title":"Nature"}],"container-title":["Science Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/scitranslmed.3000251","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T17:28:17Z","timestamp":1705426097000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/scitranslmed.3000251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,7]]},"references-count":56,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2010,4,7]]}},"alternative-id":["10.1126\/scitranslmed.3000251"],"URL":"https:\/\/doi.org\/10.1126\/scitranslmed.3000251","relation":{},"ISSN":["1946-6234","1946-6242"],"issn-type":[{"value":"1946-6234","type":"print"},{"value":"1946-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,7]]}}}